What medications can cause pancreatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Medications such as azathioprine, GLP-1 RAs, and DPP-4 inhibitors can cause pancreatitis as a side effect, and patients should be warned about the risk of pancreatitis and seek urgent medical attention if symptoms occur. Several medications can cause pancreatitis, including immunosuppressants like azathioprine 1 and certain diabetes medications such as GLP-1 RAs and DPP-4 inhibitors 1. The risk of pancreatitis varies based on individual factors, medication dose, and duration of use. Drug-induced pancreatitis typically occurs through direct toxic effects on pancreatic cells, immunologic reactions, accumulation of toxic metabolites, or by causing duct obstruction or increasing triglyceride levels.

Common Medications Associated with Pancreatitis

  • Immunossuppressants: azathioprine 1
  • Diabetes medications: GLP-1 RAs, DPP-4 inhibitors 1 Symptoms of medication-induced pancreatitis include abdominal pain, nausea, vomiting, and elevated pancreatic enzymes. If you develop these symptoms while taking any medication, seek immediate medical attention. Treatment usually involves discontinuing the offending drug and providing supportive care. Patients with a history of pancreatitis should inform their healthcare providers before starting new medications.

From the FDA Drug Label

Pancreatitis [see Boxed Warning, Warnings and Precautions (5.1)] In clinical trials using a buffered formulation of didanosine, pancreatitis resulting in death was observed in one patient who received didanosine plus stavudine plus nelfinavir, one patient who received didanosine plus stavudine plus indinavir, and 2 of 68 patients who received didanosine delayed-release capsules plus stavudine plus indinavir plus hydroxyurea In an early access program, pancreatitis resulting in death was observed in one patient who received didanosine plus stavudine plus hydroxyurea plus ritonavir plus indinavir plus efavirenz Exocrine Gland Disorders - pancreatitis (including fatal cases) [see Warnings and Precautions (5.1)], sialoadenitis, parotid gland enlargement, dry mouth, and dry eyes.

Medications that can cause pancreatitis include:

  • Didanosine
  • Stavudine
  • Hydroxyurea
  • Ritonavir
  • Indinavir
  • Efavirenz
  • Nelfinavir
  • Tenofovir disoproxil fumarate (when coadministered with didanosine)
  • Other medications that may cause pancreatic toxicity, when used with didanosine. 2, 2, 2

From the Research

Medications Implicated in Pancreatitis

The following medications have been implicated in causing pancreatitis:

  • Agents with a definite association with pancreatitis:
    • asparaginase 3, 4, 5, 6
    • azathioprine 3, 4, 5, 6
    • didanosine 3, 7
    • estrogens 3, 4, 5, 6
    • furosemide 3, 4, 5
    • mercaptopurine 3, 7
    • pentamidine 3, 7, 5, 6
    • sulfonamides 3, 4, 5, 6
    • sulindac 3, 7, 6
    • tetracyclines 3, 4, 5, 6
    • thiazides 3, 4, 5
    • valproic acid 3, 7, 5, 6
  • Agents with a probable association with pancreatitis:
    • cimetidine 3
    • clozapine 3
    • corticosteroids 3, 4, 5, 6
    • endoscopic retrograde cholangiopancreatography contrast media 3
    • methyldopa 3
    • metronidazole 3, 6
    • salicylates 3, 6
    • zalcitabine 3
  • Agents with a questionable association with pancreatitis:
    • acetaminophen 3, 7
    • cyclosporine 3, 6
    • cytarabine 3, 7
    • erythromycin and roxithromycin 3, 7
    • ketoprofen 3
    • metolazone 3
    • octreotide 7, 6

Classification of Medications Implicated in Pancreatitis

Medications implicated in pancreatitis can be classified into three classes based on the strength of evidence:

  • Class I medications: implicated in greater than 20 reported cases of acute pancreatitis with at least one documented case following reexposure 7
  • Class II medications: implicated in more than 10 cases of acute pancreatitis 7
  • Class III medications: all medications reported to be associated with pancreatitis 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-induced pancreatitis.

Clinical pharmacy, 1993

Research

[Acute drug-induced pancreatitis].

Schweizerische medizinische Wochenschrift, 1985

Research

Drug-induced acute pancreatitis: further criticism.

Digestive diseases (Basel, Switzerland), 1993

Research

Drug-induced pancreatitis: an update.

Journal of clinical gastroenterology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.